Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer
Condition(s):Triple-negative Breast CancerLast Updated:December 14, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Triple-negative Breast CancerLast Updated:December 14, 2018Unknown status
Condition(s):Triple-negative Breast CancerLast Updated:April 27, 2020Unknown status
Condition(s):Advanced Triple Negative Breast CancerLast Updated:June 28, 2023Terminated
Condition(s):Metastatic Triple-Negative Breast CancerLast Updated:January 10, 2022Unknown status
Condition(s):Triple-negative Breast CancerLast Updated:February 11, 2021Unknown status
Condition(s):Metastatic Breast Cancer; Triple Negative Breast CancerLast Updated:August 18, 2023Active, not recruiting
Condition(s):Breast Cancer; Triple Negative Breast CancerLast Updated:February 10, 2023Not yet recruiting
Condition(s):Metastatic Triple-negative Breast Cancer; Locally Advanced Triple-negative Breast CancerLast Updated:September 10, 2022Recruiting
Condition(s):Triple Negative Breast CancerLast Updated:June 4, 2021Unknown status
Condition(s):Triple-Negative Breast CancerLast Updated:March 15, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.